KRT18 and neoplasm: Compared with tumor cells at the primary site, metastatic tumor cells still retained high expressions of KRT8 and KRT18, whereas metastatic tumor cells no longer expressed MMRN1, PROX1, TCF7L1, SCG3 and SV2C (Figure 5B).